Exascale Labs Holdings Inc. (XLAB)

NASDAQ: XLAB · Real-Time Price · USD

4.485

+0.095 (2.16%)

At close: Sep 8, 2026, 4:00 PM EDT

4.400

+0.010 (0.23%)

Pre-market: Sep 9, 2026, 6:33 AM EDT

Exascale Labs Holdings Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Revenue	13.1	7.02	1.32
Revenue Growth	893.16%	431.83%	-
Gross Profit	2.12	1.11	0.06
Operating Income	-3.4	-3.04	-1.85
Net Income	-9.4	-7.66	-4.96

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Net Cash (Debt)	0.98	4.23	0.97
Net Cash Growth	1.57%	336.43%	-
Cash & Investments	0.98	4.23	0.97

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Operating Cash Flow	-4.01	-1.01	-0.56
Capital Expenditures	-	-0	-0.03
Free Cash Flow	-4.01	-1.01	-0.59
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Gross Margin	16.14%	15.75%	4.21%
Operating Margin	-25.96%	-43.40%	-139.93%
Pretax Margin	-71.74%	-109.18%	-375.73%
Profit Margin	-71.74%	-109.18%	-375.73%
FCF Margin	-30.62%	-14.44%	-44.63%